Inhibition of Mitochondrial Carrier Homolog 2 (MTCH2) Suppresses Tumor Invasion and Enhances Sensitivity to Temozolomide in Malignant GliomaQiuyun Yuan(Sichuan University), Yan‐Hui Liu(Guizhou University)Research SquareDecember 31, 202010.21203/rs.3.rs-53540/v3Cited by 2SaveCiteExport RISWatch citationsRelated PapersObservation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study|Neurosurgical Review|2020|24Inhibition of Mitochondrial Carrier Homolog 2 (MTCH2) Suppresses Tumor Invasion and Enhances Sensitivity to Temozolomide in Malignant Glioma|Research Square|2020|0